Skip to main content
SpringerLink
Log in

A model for the function of glycosaminoglycans in the urinary tract

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Investigations into the antibacterial defense mechanisms of the urinary tract revealed an important function for cell surface glycosaminoglycans (GAG), that of a generalized antiadherent activity. This activity was found to prevent bacterial, protein, and ionic adherence to the cell membrane. A model was developed to explain mechanically the activity of sulfated polysaccharides at the bladder surface. The model predicted injurious effects of quaternary amines and also that the mucus would be the so-called blood-urine barrier. It also led to the hypothesis that exogenous polysaccharides may be important in treating bladder disease such as infection and interstitial cystitis. For the first clinical test of these concepts, a polysaccharide was employed in several double-blind studies and was shown to ameliorate significantly the symptoms of interstitial cystitis. These discoveries suggest new methods to manipulate the microenvironment between the transitional cell surface and the urine, leading to novel therapies in regulating disease of the genitourinary tract. They also stress the importance of understanding the mechanisms by which GAGs exert their effect in the urinary tract and how they are produced, maintained, and even inactivated (e.g., by urinary substances such as protamine).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderstrom CR, Fall M, Johansson SL (1989) Scanning electron microscopic findings in interstitial cystitis. Br J Urol 63:270–275

    Google Scholar 

  2. Dixon JS, Holm-Bentzen M, Gilpin CJ, Gosling JA, Bostofte E, Hald T, Larsen S (1986) Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol 135:621–625

    Google Scholar 

  3. Eldrup J, Thorup J, Nielsen SL, Hald T, Hainau B (1983) Permeability and ultrastructure of human bladder epithelium. Br J Urol 55:488–492

    Google Scholar 

  4. Felsen D, Frye S, Bavendam TG, Parsons CL, Trimble LA, Vaughan ED (1993) Urinary imflammatory mediator profiles in interstitial cystitis (IC) patients, patients with IC-like symptoms, and controls (abstract). J Urol 149:507A

    Google Scholar 

  5. Gill WG, Jones KW, Ruggiero KJ (1982) Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127:152–154

    Google Scholar 

  6. Gregor HP (1976) Fixed-charge ultrafiltration membranes. In: Selegny E (ed) Charged gels and membranes, vol I. D. Reidel, p 235

  7. Gregor HP (1976) Anticoagulant activity of sulfonate polymers and copolymers. In: Gregor HP (ed) Polymer science and technology, vol 5. Plenum, New York p 51

    Google Scholar 

  8. Gryte CC, Gregor HP (1976) Poly(styrene sulfonic acid)-poly-(vinylidene fluoride) interpolymer ion-exchange membranes. J Polymer Sci 14:1839–1854

    Google Scholar 

  9. Hanno P, Levin RM, Monson FC, Teuscher C, Zhou ZZ, Ruggieri M, Whitmore K, Wein AJ (1990) Diagnosis of interstitial cystitis. J Urol 143:278–281

    Google Scholar 

  10. Hanno P, Parsons CL, Shrom S, Fritz R, Mulholland S (1978) The protective effect of intravesical heparin in experimental bladder infection. J Surg Res 25:324–329

    Google Scholar 

  11. Hohlbrugger G, Lentsch P (1985) Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol 11:127–130

    Google Scholar 

  12. Holm-Bentzen M, Jacobsen F, Nerstrom B, Lose G, Kristensen JK, Pedersen RH, Krarup T, Feggetter J, Bates P, Barnard R, Larsen S, Hald T (1987) Painful bladder disease: clinical and pathoanatomical differences in 115 patients. J Urol 138:500–502

    Google Scholar 

  13. Holm-Bentzen M, Lose G (1987) Pathology and pathogenesis of interstitial cystitis. Urology 29 [Suppl 4]:8–13

    Google Scholar 

  14. Hurst RE (1978) Thermodynamics of the partition of chondroitin sulfate-hexadecylpyridinium complexes in butanol/aqueous salt biphasic solutions. Biopolymers 17:2601–2608

    Google Scholar 

  15. Hurst RE, Jennings GC, Lorincz AE (1977) Partition techniques for isolation and fractionation of urinary glycosaminoglycans. Anal Biochem 79:502–512

    Google Scholar 

  16. Hurst RE, Rhodes SW, Adamson PB, Parsons CL, Roy JB (1987) Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 138:433–437

    Google Scholar 

  17. Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans: a human epithelial permeability barrier. Surg Gynecol Obstet 171:493–496

    Google Scholar 

  18. Lynes WL, Flynn SD, Shortliffe LD, Lemmers M, Zipser R, Roberts LJ II, Stamey TA (1987) Mast cell involvement in interstitial cystitis. J Urol 138:746–752

    Google Scholar 

  19. MacDermott JP, Miller CH, Levy N, Stone AR (1991) Cellular immunity in interstitial cystitis. J Urol 145:274–279

    Google Scholar 

  20. Menter JM, Hurst RE, Nakamura N, West SS (1979) Thermodynamics and cooperative parameters of acridine orange-heparin system. Biopolymers 18:493–505

    Google Scholar 

  21. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR (1990) Pentosan polysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology 35:552–558

    Google Scholar 

  22. Niku SD, Stein PC, Scherz HC, Parsons CL (in press) A new method for cyto-destruction of bladder epithelium using protamine sulfate and urea. J Urol

  23. Oravisto KJ (1990) Interstitial cystitis as an autoimmune disease. A review. Eur Urol 6:10–13

    Google Scholar 

  24. Parsons CL (1982) Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127:167–169

    Google Scholar 

  25. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G (in press) A quantitatively controlled method to study prospectively interstitial cystitis and that demonstrates the efficacy of pentosanpolysulfate. J Urol 150

  26. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142

    Google Scholar 

  27. Parsons CL, Greenspan C, Moore SW, Mulholland SG (1977) Role of surface mucin in primary antibacterial defense of the bladder. Urology 9:48–52

    Google Scholar 

  28. Parsons CL, Greenspan C, Mulholland S (1975) The primary antibacterial defense mechanism of the bladder. Invest Urol 13:72–76

    Google Scholar 

  29. Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in non-bacterial cystitis (interstitial cystitis). J Urol 145:732–735

    Google Scholar 

  30. Parsons CL, Pollen J, Anwar H, Stauffer C, Schmidt JD (1980) Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infect Immun 27:876–881

    Google Scholar 

  31. Parsons CL, Schmidt JD, Pollen J (1983) Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 130:51–53

    Google Scholar 

  32. Parsons CL, Stauffer C, Schmidt JD (1980) Bladder surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208:605–607

    Google Scholar 

  33. Parsons CL, Stauffer C, Schmidt JD (1981) Impairment of antibacterial effect of bladder surface mucin by protamine sulfate. J Infect Dis 144:180

    Google Scholar 

  34. Parsons CL, Stauffer CW, Schmidt JD (1988) Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate. Infect Immun 56:1341–1343

    Google Scholar 

  35. Parsons CL, Stein PC, Bidair M, Lebow D (in press) Abnormal sensitivity to intravesical potassium in interstitial cystitis. Neurourol Urody

  36. Uehling DT, Mizutani K, Balish E (1980) Inhibitors of bacterial adherence to urothelium. Invest Urol 18:40–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, UCSD Medical Center, San Diego, California, USA

    C. L. Parsons

Authors
  1. C. L. Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by the Medical Research Service of the Veterans Administration, Urological Research and Education Foundation, and by National Institutes of Health grant R01DK39239.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsons, C.L. A model for the function of glycosaminoglycans in the urinary tract. World J Urol 12, 38–42 (1994). https://doi.org/10.1007/BF00182049

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182049

Keywords

Search

Navigation